# Missed Friday’s Executive Webinar? Watch the Recording | Sen-Jam Pharmaceutical

- Canonical URL: https://wefunder.com/feed/272930
- Entity ID: wefunder:feed_item:272930
- Published at: 2026-03-09 17:01:57 UTC
- Updated at: 2026-03-10 02:25:36 UTC

## Author
Christine Leonard

## Subject
Sen-Jam Pharmaceutical

## Content
Dear Sen-Jam Investors and Followers,If you weren’t able to join us live last Friday for our executive webinar, we’re pleased to share the full recording.Illuminating the Pathway: Building the Next Evolution of Prevention-Led Inflammation Control was a dynamic session with a large and highly engaged audience. The discussion covered both the science and strategy shaping Sen-Jam’s next phase of development.During the briefing, our executive team walked through:• Where the Phase II analysis currently stands• What safety confirmation and the combination rule mean for SJP-001• Our regulatory strategy through the 505(b)(2) pathway• Potential next steps in the clinical program• Manufacturing readiness and OTC positioning• How SJP-001 serves as the foundation for our broader longevity-focused inflammation platformWe also addressed a wide range of thoughtful questions from attendees about the clinical data, regulatory strategy, commercialization pathway, and the broader platform opportunity.If you missed the live session, we invite you to watch the recording here:▶ Watch the Webinar RecordingThank you again for your continued support and engagement as we advance this platform.Warm regards,ChristineForward-looking statements apply. All projections and expectations are subject to risk and uncertainty.